Katerina Akassoglou/Gladstone Institutes
Oct 21, 2025, 06:18
Katerina Akassoglou Receives Zenith Fellows Award to Advance Alzheimer’s Research
Gladstone Institutes shared on LinkedIn:
”Katerina Akassoglou has opened doors to understanding how the blood protein fibrin is involved in Alzheimer’s and other neurodegenerative diseases.”
Katerina Akassoglou, PhD, of the Gladstone Institutes, has led groundbreaking research into the interplay between the brain, blood vessels, and immune system, revealing how these connections contribute to Alzheimer’s and other neurological disorders.
In recognition of her work, she has been named a 2025 recipient of the Alzheimer’s Association’s Zenith Fellows Award.
Read the full article here.
More winner stories featured in Hemostasis Today.
-
Mar 16, 2026, 19:16Maha Othman: Delighted to See Our Article Receive The Eberhard F. Mammen Most Popular Article Award 2026
-
Mar 16, 2026, 19:03Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
-
Mar 16, 2026, 18:59Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
-
Mar 16, 2026, 18:54Michael Recht Appointed Chief Medical and Scientific Advisor to NBDF’s Pathway to Cures
-
Mar 16, 2026, 18:46David McIntosh: Moving Beyond Doubts and Ensuring the Safety of Plasma Donation
-
Mar 16, 2026, 18:42Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
-
Mar 16, 2026, 18:27Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
-
Mar 16, 2026, 18:20Ahmed Koriesh: Stroke Prevention in the New 2026 ACC/AHA Dyslipidemia Guideline
-
Mar 16, 2026, 18:13Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation